Cargando…

Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals

SIMPLE SUMMARY: Lung cancer remains one of the deadliest cancers, with the worst survival rate. Cells from the airway lining of patients at high risk for lung cancer differentially express proteins that may serve as biomarkers for early detection of lung cancer. Previously, we identified candidate p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, S.M. Jamshedur, Chen, Sheau-Chiann, Wang, Yi-Ting, Gao, Yuqian, Schepmoes, Athena A., Fillmore, Thomas L., Shi, Tujin, Chen, Heidi, Rodland, Karin D., Massion, Pierre P., Grogan, Eric L., Liu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526486/ https://www.ncbi.nlm.nih.gov/pubmed/37760474 http://dx.doi.org/10.3390/cancers15184504

Ejemplares similares

Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer
por: Song, Ehwang, et al.
Publicado: (2017)

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
por: Wang, Hui, et al.
Publicado: (2017)

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
por: Gao, Yuqian, et al.
Publicado: (2020)

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods
por: He, Jintang, et al.
Publicado: (2015)

Expediting SRM Assay Development for Large-Scale Targeted Proteomics Experiments
por: Wu, Chaochao, et al.
Publicado: (2014)

Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas
por: Nakajima, Erica C., et al.
Publicado: (2018)

Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness
por: Vasiukov, Georgii, et al.
Publicado: (2023)

Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules
por: Massion, Pierre P., et al.
Publicado: (2020)

Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins
por: Shi, Tujin, et al.
Publicado: (2017)

TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk
por: Craig, Daniel J., et al.
Publicado: (2023)

Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma
por: Kammer, Michael N., et al.
Publicado: (2023)

Hashimoto’s Thyroiditis and the Risk of Papillary Thyroid Cancer in Children
por: Gallant, Jean-Nicolas, et al.
Publicado: (2023)

Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer
por: Wang, Yi-Ting, et al.
Publicado: (2020)

Facile carrier-assisted targeted mass spectrometric approach for proteomic analysis of low numbers of mammalian cells
por: Shi, Tujin, et al.
Publicado: (2018)

The Advance of Personalized and Stratified Therapies in Bronchial Asthma: Phenotypes – Endotypes – Biomarkers
por: Lauer, Sebastian, et al.
Publicado: (2014)

Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement
por: Petro, James B., et al.
Publicado: (2000)

Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma
por: Hinson, H.E., et al.
Publicado: (2021)

Risk-Stratifying Pulmonary Nodules
por: Wilson, David O.
Publicado: (2021)

Risk-Stratified Treatment in Chronic Lymphocytic Leukemia
por: Stephens, Deborah M., et al.
Publicado: (2016)

Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: Assessment of pharmacokinetics, toxicity and efficacy using a rabbit model
por: Daniels, Anthony B., et al.
Publicado: (2021)

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
por: Ji, Xiangming, et al.
Publicado: (2018)

Self-Knowledge and Risk in Stratified Medicine
por: Hordern, Joshua
Publicado: (2017)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Risk score to stratify miscarriage risk levels in preconception women
por: Choo, Xin Hui, et al.
Publicado: (2021)

Reply to Wilson: Risk-Stratifying Pulmonary Nodules
Publicado: (2021)

The current status of risk-stratified breast screening
por: Clift, Ash Kieran, et al.
Publicado: (2021)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
por: Zhang, Qibin, et al.
Publicado: (2013)

Risk Stratified Follow-Up for Endometrial Cancer: The Clinicians’ Perspective
por: Amirthanayagam, Anumithra, et al.
Publicado: (2023)

Weighted Moments Estimators of the Parameters for the Extreme Value Distribution Based on the Multiply Type II Censored Sample
por: Wu, Jong-Wuu, et al.
Publicado: (2013)

Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes
por: Xu, Zhe, et al.
Publicado: (2014)

Safety risk management for low molecular weight process‐related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential
por: Luo, Haibin, et al.
Publicado: (2021)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis
por: Lomzenski, Hannah E., et al.
Publicado: (2022)

Can laboratory blood tests be used to risk stratify patients admitted with pneumonia?
por: Apps, L, et al.
Publicado: (2014)

Cervical Mucus Properties Stratify Risk for Preterm Birth
por: Critchfield, Agatha S., et al.
Publicado: (2013)

Risk stratifying the screening of Barrett's esophagus: An Asian perspective
por: Sharma, Neel, et al.
Publicado: (2017)

Risk-Stratifying COVID-19 Patients the Right Way
por: Minardi, Joseph, et al.
Publicado: (2020)

Engraftment characterization of risk-stratified AML in NSGS mice
por: Díaz de la Guardia, Rafael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nrssdtrrnu75g53eak731acfs8